Latest Funding News

Carnaby Resources reports promising assay results from its Trekelano drilling program and maintains a robust cash balance as it advances the Greater Duchess Copper Gold Project towards a Q3 2025 Pre-Feasibility Study completion.

Vital Metals’ latest Scoping Study for its Tardiff deposit in Canada reveals strong economic potential, underpinning an 11-year mine life with significant rare earth and niobium production. The company plans to advance to a Prefeasibility Study by the end of 2026, aiming to optimize recoveries and expand resources.

Odyssey Gold Limited has advanced its Tuckanarra Gold Project with a new mill access agreement, ongoing drilling, and a $4 million capital raise, positioning the company for a potential resource upgrade.

Viridis Mining and Minerals has raised AU$11.5 million through a heavily oversubscribed placement, strengthening its balance sheet to advance the Colossus Rare Earth Project towards Final Investment Decision. The funding, backed by institutional and strategic Brazilian partners, positions Viridis with nearly AU$58.5 million in cash to accelerate development and regulatory approvals.

Lord Resources has secured government co-funding and completed key surveys, setting the stage for its inaugural drilling campaign at the Ilgarari Copper Project in Western Australia.

Terra Metals has raised $4 million from strategic investors to fund further exploration at its Dante Project, where recent drilling confirms high-grade mineralisation and supports a forthcoming maiden resource estimate.

ACDC Metals has reported strong scoping study results for its Goschen Central heavy mineral sands and rare earth project, highlighting a promising 14-year mine life and a strategic retention licence application to support ongoing development.

Core Lithium has repositioned its Finniss Lithium Project as a low-cost underground operation with a 20-year mine life, slashing operating costs by a third and boosting production capacity. The company is advancing strategic funding while unlocking flexibility through a key offtake agreement termination.

Neurizon Therapeutics has made significant strides in developing its lead ALS drug candidate NUZ-001, unveiling a new liquid formulation and submitting a key regulatory response to the FDA. Clinical and preclinical data bolster hopes for broader neurodegenerative applications.

Pinnacle Minerals Ltd has announced a $1.76 million capital raise through a two-tranche share placement with free attaching options, aiming to advance its exploration projects in Canada and Australia.

G50 Corp has reported a significant new discovery of gold, silver, and zinc at its Golconda Project in Arizona, alongside promising gallium mineralogy results that could enhance extraction methods.

Neurizon Therapeutics has secured a $1.5 million loan against its expected 2025 R&D tax rebate, boosting liquidity without diluting shareholders. This strategic move supports ongoing development of its neurodegenerative disease treatments.